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Eliciting meta consent for future secondary
research use of health data using a
smartphone application - a proof of
concept study in the Danish population
Thomas Ploug1* and Søren Holm2,3,4
Abstract
Background: The increased use of information technology in every day health care creates vast amounts of stored
health data that can be used for research. The secondary research use of routinely collected data raises questions
about appropriate consent mechanisms for such use. One option is meta consent where individuals state their own
consent preferences in relation to future use of their data, e.g. whether they want the data to be accessible to
researchers under conditions of specific consent, broad consent, blanket consent or not at all.
This study investigates whether meta consent preferences can be successfully elicited by a smartphone application
in the adult Danish population.
Methods: A smartphone app was developed for the elicitation of meta consent preferences. An invitation to use
the app was distributed to a stratified, representative sample of the Danish adult population. The meta consent
choices, the use of the app, user experience data, and demographic data were logged and analysed statistically
using IBM SPSS version 20.
Results: Of 1000 potential respondents 221 used the app. One hundred eighty-eight of the respondents were female
and 103 male. The age range was 19 to 79 years with an average of 51 years (SD 16). Most users indicate 1) that they
find the choices they are asked to make easy to understand (>75% find it ‘Easy’ or ‘Very easy’), 2) that the application is
easy to use (>75% find it ‘Easy’ or ‘Very easy’), and 3) that this kind of choice should be offered to people (89% find it
‘Absolutely’ or ‘Somewhat’ important).
Conclusions: It is possible to collect meta consent preferences in the general, adult population using a smartphone app.
Keywords: Blanket consent, Broad consent, Meta consent, Proof of concept, Specific consent, Secondary research use of
health data, Smartphone application
Background
The meta consent model
The pervasive use of information and communication
technology in the health care sector creates new oppor-
tunities for research under the banner of ‘Big Data’ [1, 2].
Vast amounts of data collected and stored by different
health care institutions may potentially be linked and
analysed, and may also be linked to other databases
holding non-health related information. A key ethical
concern is whether data collected as part of health
care can be used for ‘secondary’ research without
renewed consent [3–12].
A requirement of informed consent cannot be waived,
it may be argued, for at least four reasons: 1) It allows
individuals to express approval or disapproval of the
purpose of – including the values, methods, interests in-
herent in – a research project. 2) It allows individuals to
protect themselves against harms ensuing from the use
of their data, including e.g. stigmatisation of their peer
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group and medicalization. 3) It allows individuals to pro-
tect their privacy by controlling the use of what they
consider to be private and sensitive information. 4) It
protects trust in health care professionals by involving
people in decisions about the use of their data.
However, if a requirement of informed consent is main-
tained for every single, specific research project in which in-
dividuals’ health care data is used it may impede valuable
research by imposing on researchers the practical burden
of obtaining consent. And, even worse, it may lead to the
routinisation of informed consent, i.e. that consent is being
provided or refused as an unreflective, habitual act [13, 14].
This may happen as a result of individuals being asked too
often about consent. If the provision or refusal of consent
becomes routinised – i.e. provided or refused out of habit
and without reflection – it clearly loses its ability to protect
individuals and their interests as sketched in 1)-4) above.
One solution to this apparent dilemma may be found in
the notion of ‘meta consent’ [15, 16]. Meta consent denotes
the idea that individuals should be asked how and when
they would like to provide consent. As such meta consent
is a matter of designing future consent requests. The design
process essentially consists in an individual choosing 1) a
type of consent for each 2) type of data or type of context,
from a set of predefined options. Table 1 shows a non-
exhaustive list of possible categories for 1) and 2):
An individual choosing ‘specific consent’ for ‘Electronic
patient record’ thereby states that s/he wants to be asked
for consent to every future research project in which
health data from his or her electronic patient record is be-
ing used. A choice of ‘blanket refusal’ for ‘commercial re-
search’ means that the individual has refused all future use
of his or her health data in a commercial context. In an
implementation of meta consent individuals should be
able to change these meta consent choices whenever they
want to do so, and should be reminded to revisit their
meta consent choices at regular intervals.
A model of meta consent is sensitive to individual
preferences for how and when to provide consent, and
this sensitivity may increase the likelihood of individuals
reflecting upon their future provision or refusal of con-
sent. At the same time a model of meta consent allows
for broad and blanket consent, thereby potentially
alleviating the practical burden on researchers and redu-
cing the risk of routinisation.
However, while meta consent seem a neat solution in
principle, it is far from obvious that ‘meta choices’ of
this kind works in practice. In this article we report and
analyse the results of a proof of concept implementation
of meta consent as a front end application for smart-
phones and tablets. We investigate 1) whether Danish
citizens are able to use a meta consent app, 2) whether
they understand the choices presented, 3) how they use
the app, and 4) whether they think that the choices are
valuable. It is important to note that in Denmark it is
currently legal to perform research on health data with-
out consent if the data are anonymised before they are
provided to the researchers. Such research does not re-
quire research ethics approval either. This situation is
likely to continue after the implementation of the EU
General Data Protection Regulation (GDPR) in 2018.
Article 89 of the GDPR allows for national derogation
from consent requirements for use of data for scientific
research purposes, and Denmark is likely to use this pos-
sibility. An introduction of meta consent will thus in the
Danish context allow people more control of their data
than they currently have.
The practical Implementation of meta consent also re-
quires a back end. That is a technological infrastructure at
the societal level that enables the collection of meta con-
sent, the storage of meta consent choices, the generation
of specific consent requests depending on the meta
choices, and the two way communication between indi-
viduals and researchers of specific consent requests and
decisions. This could be implemented relatively easily in
countries where individuals are identifiable through a
unique personal identification code, and where citizens
are already required to have a publicly authorised elec-
tronic mailbox (in Denmark and Norway, for example). In
these countries, the personal identification code is already
used to link data for epidemiological research and to dir-
ect mail to the mailbox. Implementing a further link to a
consent request generator would be straightforward [15].
The current study and recent research on informed
consent
Two relevant strands in recent discussions on informed
consent should be mentioned here.
The model of meta consent presents only one possible
strategy in the attempt to overcome the problem of routin-
isation and consent fatigue. Recent literature on informed
consent has stressed the importance of tailoring the on-
going information and communication about research to
individual informational needs by empowering individuals
to take part in the design of the information exchange
through a dynamic, web-based platform [17, 18]. Key in the
discussion of these different models of informed consent is
Table 1 Types of consent, data and contexts
Type of consent Type of data
or context




Broad consent: Consent to broad categories
of research
Data from samples
Blanket consent: Consent to all research Commercial research
Blanket refusal: Refusal of all research use …
Ploug and Holm BMC Medical Ethics  (2017) 18:51 Page 2 of 8
the question of whether a choice to provide broad or blan-
ket consent for future research can be informed since it
cannot be founded on specific information about specific
research projects [19–24]. If a choice to provide broad of
blanket consent cannot be informed, this will obviously
pose a problem for any consent model allowing broad or
blanket consent, including the meta consent model. We be-
lieve that such choices can be informed in the sense that
they can rest on general information about future research,
and this information may well in many cases satisfy individ-
ual preferences for information. And, if it does not satisfy
individual preferences for information, the model of meta
consent provides individuals with the option of requiring to
be asked for consent to each specific, future research pro-
ject on the basis of specific information about these pro-
jects. However, in this article we do not aim to give an
exhaustive treatment of strengths and weaknesses of alter-
native models of consent but rather to present the results
of an empirical study of an electronic implementation of
meta consent.
A second relevant strand in recent literature on in-
formed consent concerns the feasibility of implementing
informed consent processes in a digital setup. Several
digital models and solutions have been suggested in the
scientific literature [25–28], and different commercial
electronic solutions have emerged (Secure Consent, WCG
eConsent, iCONS eConsent [29–31]). Common to these
are that they aim to make the consent process easier for
patients in order to increase patient participation in the
consent process. The current study also focuses on an
electronic implementation of consent. It differs from pre-
vious studies and solutions in two respects. First, it does
not concern consent for a specific clinical trial, or other
specified research project but rather consent for all future
secondary use of health data collected in the clinical con-
text. Second, and relatedly, it primarily studies meta pref-
erences for consent, i.e. it studies peoples’ preferences for
how and when to provide consent in relation to prede-
fined categories of research.
Methods
App development
The application was developed on the basis of four initial
criteria: 1) Users should be provided with information
about the collection and potential research use of their
health care data in the Danish health care sector, and they
should be given information about the purpose of the appli-
cation. 2) Users should be given an explanation of the four
types of consent outlined above. 3) Users should be given
information about the various types of data and research
contexts and then be provided with the possibility to
choose the format of future consent requests. The types of
data reflect the most common data types held in Danish
registries, and the types of research the types most
commonly mentioned in Danish public debate. Moving be-
yond a proof of concept study would require a much more
rigorous process for choosing and defining these types, and
they might differ from country to country. 4) Users should
be provided with an overview of their choices and an esti-
mate of how their consent choices would a) affect them in
terms of the number of future consent requests, and b)
limit the research use of their data. A choice of specific con-
sent for data types and contexts would thus entail many fu-
ture consent requests to the individual and a significant
limitation of research, whereas a choice of blanket consent
to all data types and contexts would entail no future con-
sent requests to the individual and no limitation of
research.
These four criteria along with common user interface
considerations formed the basis for the user-centred devel-
opment of a paper prototype, a mockup and the final appli-
cation for Android and iOS platforms by professional app
developing company Syntac Studios. Figures 1 and 2 below
Fig. 1 Consent Types. The four different types of consent
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show two of the main screens in the final application
(Additional file 1 contains a translation from Danish of all
the screens in the app including the ‘Help’ screens).
User expectations to content and layout of the paper
prototype and the image-based mockup prototype was
tested on 6 and 8 subjects. They were asked “To what de-
gree does the contents and layout of the screen fulfill your
expectations?” Using a Likert scale from 1 to 5 with 1 be-
ing “Horrible” and 5 “Perfect”, the paper prototype and
the image-based mockup prototype scored an average per
screen of 3.5-4.1 and 4.25-4.5 respectively. The first full
application prototype was tested on 31 subjects using the
standard extensively validated, 10 item System Usability
Scale and scored an average 75 on a scale from 1 to 100
[32]. A score of 68 or above indicates that a system is easy
to approach and intuitive [33]. Participants for these tests
where recruited through an e-mail to students and em-
ployees of the Department of Communication, Aalborg
University, Copenhagen, and through Syntac Studio’s list
of contacts.
Sample
A random, stratified sample of 1000 potential respon-
dents, representative of the adult Danish population was
drawn from TNS Gallup’s Danish panel. The sample was
stratified according to gender, age and residential region.
The background panel consists of approximately 53,000
persons. Potential respondents were contacted by e-mail
by TNS Gallup, with further reminders by e-mail and
SMS to those who had not either 1) stated that they did
not have a suitable smartphone or tablet, or 2) declined
participation. An incentive for participation was
provided in the form of entry into a prize draw for a
number of vouchers with a value of 300 DKK.
Analysis
Data from the app were captured by a server back end
and exported to SPSS IBM Statistics version 20 and ana-
lysed using the SPSS table and regression functions [34].
Ethics
The study collected anonymous data only and therefore
does not require research ethics approval in Denmark.
Participation is completely voluntary and the questions
asked are not particularly sensitive or likely to cause
distress.
Results
An invitation to participate in the study was sent by e-
mail to 1000 potential respondents in May 2016. One
hundred eighty-eight were excluded because they did
not have a smartphone or tablet and 2 for other reasons.
Four hundred seven did not wish to participate. Of the
remaining 403 potential participants, 305 activated the
link to the app and 221 used and completed the app.
The response rate is thus 22.1% of the total sample, and
27.2% of the sample having smartphones or tablets.
Compared with the stratification variables (Gender, Age
and Region) the sample efficiency was 89% (Sample Effi-
ciency = n2  nPiw2i Þ.
One hundred eighteen of the respondents were female
and 103 male. The age range was 19 to 79 years with an
average of 51 years (SD 16). The educational level of the
respondents were ‘7-10 years of school’ 35 (15.8%), ‘11-
13 years of school’ 65 (29.4%), ‘Short university education
(less than 3 years)’ 27 (12.2%), ‘Medium university educa-
tion (3–4.5 years)’ 70 (31.7%), ‘Long university education
(5 years or more)’ 24 (10.9%). The educational level in the
general Danish population 15 to 69 years old in 2016 were
‘7-10 years of school’ 16.3%, ‘11–13 years of school’ 39.7%,
‘Short university education’ 6.4%, ‘Medium university
education’ 13.6%, ‘Long university education’ 7.4%, and
‘Not known’ 5.6% (Data extracted from Statistics
Fig. 2 Consent for Data Types. An example of meta consent
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Denmark, Statistikbanken, Disced-15 classification of
highest educational level) [35].
The respondents’ assessment of the difficulties of un-
derstanding the choices they had to make is presented in
Table 2, and their actual choices in Table 3.
The movements of the respondents through the app
were logged and the time used on each of the main
screens is shown in Table 4. The distributions of times
are skewed to the right and we therefore present median
and quartiles. The respondents could click on informa-
tion bubbles to get more information about data types
and research types. Thirty-two percent of respondents
sought further information at least once.
We used multivariate linear regression analysis to ex-
plore the associations between the time used in the app
as the dependent variable and age, gender and an ad hoc
“Ease of use” scale constructed by adding the responses
to the four questions about perceived difficulty of
choices (Table 2) as the independent variables. The ana-
lysis shows a statistically significant, but weak positive
association between age and time used in the app
(Model R [2] = 0.061, p(age) = 0.006, Beta(age) = 0.227),
and no significant associations with either gender or the
Ease of use scale in the multivariate model.
After having made and confirmed their choices re-
spondents were asked how important it is that citizens
in Denmark are provided with the opportunity to make
these choices with answers on a 5 point Likert scale
from “Absolutely not important” to “Absolutely import-
ant”. 149 (67.4%) found it to be absolutely important, 48
(21.7%) somewhat important, 16 (7.2%) expressed a neu-
tral opinion, and 8 (3.6%) found it somewhat unimport-
ant. No respondent stated that providing these choices
to citizens was absolutely not important.
Discussion
The response rate is low. The good sample efficiency in-
dicates, however, that the respondents do not differ
markedly from the initial sample with respect to the
three stratification variables: gender, age, and residential
region. The respondents have a slightly higher
educational level than the average Danish population,
and it is likely that the people who used the app are
more able and willing to use IT technology than the
average Danish citizen. The results may therefore to
some extent overestimate how well the choices are
understood and how easy the app is to use. The results
never the less indicate that the respondents feel that they
understand the choices they are asked to make and that
the app in itself is easy to use. The mean age of respon-
dents of 51 years indicates that the app was not only
tested by ‘young digital natives’.
Subjectively reported understanding and ease of use
are important in order to maintain the users’ motivation
to engage in consent procedures. Thus the results show
that it is possible to design an informed consent app that
does not undermine motivation. Objectively establishing
understanding is important in order to secure that the
relevant consent procedures actually provide the individ-
ual with control and protect individual interests. Future
testing of meta consent should therefore not only in-
clude self-reported understanding but also objective
measures of understanding.
The consent choices made strongly indicate that there
are significant differences in consent preferences within
the Danish population. Very few do not want their data
used for any kind of research, and many are willing to
let their data be used without specific consent, especially
in the case of public research. However the majority
consistently across data and research types want some
control over the use of their data. This latter point is
also substantiated by the answers to the question con-
cerning whether Danish citizens should be provided with
the opportunity to make meta consent choices. Under-
neath these general trends are found noteworthy differ-
ences in the consent preferences. Around twice as many
want to be asked for specific consent for commercial re-
search and for international research than for public re-
search. The number of people wanting to be asked for
specific consent impacts research. A high number will
increase the practical burden of obtaining consent for
every research project, and it may also indicate a level of
scepticism towards the relevant type of research that
may eventually lead to more people refusing consent for
specific projects of the relevant type. The latter effect
may lead to consent bias [36, 37]. These effects on re-
search should, however, be seen in light of the general
trends that very few refuse consent to all research use of
Table 2 Perceived difficulty of choices
1 Very difficult 2 3 4 5 Very easy
How easy was it to understand the different types of consent? 0a 9 (4.1) 29 (13.1) 58 (26.2) 125 (56.6)
How easy was it to understand the different types of data and
types of research?
2 (0.9) 14 (6.3) 41 (18.6) 70 (31.7) 94 (42.5)
How easy was it to understand the choices you were asked to
make?
1 (0.5) 16 (7.2) 33 (14.9) 60 (27.1) 111 (50.2)
How easy was it to use the app? 1 (0.5) 0 10 (4.5) 40 (18.1) 170 (76.9)
N = 221 a n (%)
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data, and a high number of people are willing to provide
broad or blanket consent to research. And, the potential
effects on research must be weighed against the previ-
ously listed reasons for protecting individuals through a
requirement of informed consent (avoiding harm, pro-
tection of autonomy, privacy and trust). The wider dis-
cussion of how research and societal interests should be
balanced against individuals’ interests is outside the
scope of this article.
People who had a prior interest in the issues surround-
ing biomedical research may have been more likely to
participate in the testing of the app, which may also
skew the actual choices made. The very low level of re-
spondents choosing blanket refusal to all use of their
data, however seems to indicate that people with very
strong views against research are not overrepresented in
the sample.
The results concerning the time used in the app is
consistent with the overall finding that the users find it
easy to understand the information provided and to use
the application. There is no reason to believe that the
‘median user’ did not take the task seriously, and the
median time of approximately 4.5 min indicate that in-
formation about consent types, types of data and types
of research may be processed and choices made within a
very reasonable amount of time. However, the results
clearly also indicate that some respondents probably did
not take the task sufficiently seriously. In this study it
was made clear to respondents that this was only a test
of the application, and that their choices had no real life
effects. In a real implementation of a meta consent sys-
tem citizens would be aware that they made real choices
of significant importance and would therefore be likely
to take the task more seriously.
If a meta consent model is officially introduced it will
very likely be accompanied by a major public informa-
tion campaign about the available choices. This might
change peoples’ perception of some or all of the choices,
so the results from this study can only provide an indi-
cation of what meta consent choices the Danish popula-
tion might make. It is, however highly unlikely that
further information about the research use of health and
other data would change the view of all of the respon-
dents and move them into the category of those persons
who are willing always to let their data be used without
any kind of prior consent. Meta consent choices are re-
visable, and it is also likely that some people will modify
their initial choices in light of the consent requests they
will receive or not receive. Some may want to restrict
the frequency consent requests and others may want to
receive requests for particular types of data or research
more often.
Table 3 Meta consent preferences








Electronic patient record 1 (0.5)a 90 (40.7) 39 (17.6) 91 (41.2)
Health data in registries 2 (0.9) 74 (33.5) 43 (19.5) 102 (46.2)
Data from samples 1 (0.5) 83 (37.6) 40 (18.1) 97 (43.9)
Other data in registries 2 (0.9) 97 (43.9) 47 (21.3) 75 (33.9)
Type of research
Public research 3 (1.4) 66 (29.9) 52 (23.5) 100 (45.2)
Private commercial research 9 (4.1) 137 (62.0) 41 (18.6) 34 (15.4))
Private non-commercial research 4 (1.8) 113 (51.1) 52 (23.5) 52 (23.5)
Danish research 4 (1.8) 79 (35.7) 54 (24.4) 84 (38.0)
International research 7 (3.2) 121 (54.8) 46 (20.8) 47 (21.3)
N = 221 a n (%)
Table 4 Time use on app pages








Minimum 1.2 1.2 1.4 1.2 48.4
25% percentile 22.7 25.3 19.5 7.7 195.6
Median 32.0 39.2 30.0 17.8 263.5
75% percentile 47.8 65.4 47.7 31.6 380.9
Maximum 263.0 236.3 281.2 506.2 1293.8
N = 221 aThe times for the individual pages do not sum to the total time, since the app contains an introductory and a thank you page, a demographic
questionnaire, as well as optional further information pages
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Conclusion
This study has shown that it is possible to elicit meta
consent preferences, i.e. preferences for future consent
to secondary use of data for research, through the use of
a specifically designed smartphone application. Most
users indicate 1) that they find the choices they are
asked to make easy to understand, 2) that the applica-
tion is easy to use, and 3) that this kind of choice should
be offered to people.
The study also shows that people have significantly
different consent preferences, thus underscoring the
need for a nuanced consent system such as meta
consent.
The study thus provides proof of concept for the use
of a front end meta consent application used by citizens.
Additional file
Additional file 1: The appendix contains a translation of each of the
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